Company Filing History:
2 out of 10 
2 out of 3 Years Active: 2024-2025
Title: Ivelisse Sánchez Díaz: Innovator in Gene Therapy
Introduction
Ivelisse Sánchez Díaz is a prominent inventor based in Badalona, Spain. She has made significant contributions to the field of gene therapy, particularly in the treatment of Friedreich's ataxia. With a total of 2 patents, her work is paving the way for innovative medical solutions.
Latest Patents
One of her latest patents focuses on gene therapies for Friedreich's ataxia. This invention provides a nucleic acid, cloning vector, and transfer vector for the production of an adeno-associated virus (AAV) vector. The nucleic acid comprises a sequence encoding frataxin, a phospho-glycerate-kinase (PGK) promoter, and a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE). Additionally, the invention includes a pharmaceutical composition that comprises the AAV vector or nucleic acid, which can be utilized as a medicament for treating Friedreich's ataxia.
Career Highlights
Throughout her career, Ivelisse has worked with notable organizations such as Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol and Gentec, S.A. Her experience in these institutions has allowed her to develop her expertise in gene therapy and contribute to groundbreaking research.
Collaborations
Ivelisse has collaborated with esteemed colleagues, including Antoni Matilla Dueñas and Eudald Balagué Cabasés. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Ivelisse Sánchez Díaz is a trailblazer in the realm of gene therapy, with her inventions offering hope for those affected by Friedreich's ataxia. Her dedication to research and collaboration continues to drive advancements in medical science.